These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 14498822)

  • 21. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria].
    Ellekvist P; Colding H
    Ugeskr Laeger; 2006 Mar; 168(13):1314-7. PubMed ID: 16579884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of a selective inhibitor to define the chemotherapeutic potential of the plasmodial hexose transporter in different stages of the parasite's life cycle.
    Slavic K; Delves MJ; Prudêncio M; Talman AM; Straschil U; Derbyshire ET; Xu Z; Sinden RE; Mota MM; Morin C; Tewari R; Krishna S; Staines HM
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2824-30. PubMed ID: 21402842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraerythrocytic Plasmodium falciparum expresses a high affinity facilitative hexose transporter.
    Woodrow CJ; Penny JI; Krishna S
    J Biol Chem; 1999 Mar; 274(11):7272-7. PubMed ID: 10066789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural Basis for Blocking Sugar Uptake into the Malaria Parasite Plasmodium falciparum.
    Jiang X; Yuan Y; Huang J; Zhang S; Luo S; Wang N; Pu D; Zhao N; Tang Q; Hirata K; Yang X; Jiao Y; Sakata-Kato T; Wu JW; Yan C; Kato N; Yin H; Yan N
    Cell; 2020 Oct; 183(1):258-268.e12. PubMed ID: 32860739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies with the Plasmodium falciparum hexokinase reveal that PfHT limits the rate of glucose entry into glycolysis.
    Tjhin ET; Staines HM; van Schalkwyk DA; Krishna S; Saliba KJ
    FEBS Lett; 2013 Oct; 587(19):3182-7. PubMed ID: 23954294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue.
    Sonoiki E; Ng CL; Lee MC; Guo D; Zhang YK; Zhou Y; Alley MR; Ahyong V; Sanz LM; Lafuente-Monasterio MJ; Dong C; Schupp PG; Gut J; Legac J; Cooper RA; Gamo FJ; DeRisi J; Freund YR; Fidock DA; Rosenthal PJ
    Nat Commun; 2017 Mar; 8():14574. PubMed ID: 28262680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification, expression and characterisation of a Babesia bovis hexose transporter.
    Derbyshire ET; Franssen FJ; de Vries E; Morin C; Woodrow CJ; Krishna S; Staines HM
    Mol Biochem Parasitol; 2008 Oct; 161(2):124-9. PubMed ID: 18638508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An overview of the Plasmodium falciparum hexose transporter and its therapeutic interventions.
    Jiang X
    Proteins; 2022 Oct; 90(10):1766-1778. PubMed ID: 35445447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutational analysis of the hexose transporter of Plasmodium falciparum and development of a three-dimensional model.
    Manning SK; Woodrow C; Zuniga FA; Iserovich P; Fischbarg J; Louw AI; Krishna S
    J Biol Chem; 2002 Aug; 277(34):30942-9. PubMed ID: 12042321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmodium falciparum encodes a conserved active inhibitor-2 for Protein Phosphatase type 1: perspectives for novel anti-plasmodial therapy.
    Fréville A; Cailliau-Maggio K; Pierrot C; Tellier G; Kalamou H; Lafitte S; Martoriati A; Pierce RJ; Bodart JF; Khalife J
    BMC Biol; 2013 Jul; 11():80. PubMed ID: 23837822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs.
    Herman JD; Pepper LR; Cortese JF; Estiu G; Galinsky K; Zuzarte-Luis V; Derbyshire ER; Ribacke U; Lukens AK; Santos SA; Patel V; Clish CB; Sullivan WJ; Zhou H; Bopp SE; Schimmel P; Lindquist S; Clardy J; Mota MM; Keller TL; Whitman M; Wiest O; Wirth DF; Mazitschek R
    Sci Transl Med; 2015 May; 7(288):288ra77. PubMed ID: 25995223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclin-dependent protein kinases as therapeutic drug targets for antimalarial drug development.
    Waters NC; Geyer JA
    Expert Opin Ther Targets; 2003 Feb; 7(1):7-17. PubMed ID: 12556199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmodial sugar transporters as anti-malarial drug targets and comparisons with other protozoa.
    Slavic K; Krishna S; Derbyshire ET; Staines HM
    Malar J; 2011 Jun; 10():165. PubMed ID: 21676209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Farnesyltransferase Inhibitor R115777 on Mitochondria of Plasmodium falciparum.
    Ha YR; Hwang BG; Hong Y; Yang HW; Lee SJ
    Korean J Parasitol; 2015 Aug; 53(4):421-30. PubMed ID: 26323840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and functional characterization of the PfNT1 nucleoside transporter gene from Plasmodium falciparum.
    Carter NS; Ben Mamoun C; Liu W; Silva EO; Landfear SM; Goldberg DE; Ullman B
    J Biol Chem; 2000 Apr; 275(14):10683-91. PubMed ID: 10744765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial type II NADH dehydrogenase of Plasmodium falciparum (PfNDH2) is dispensable in the asexual blood stages.
    Ke H; Ganesan SM; Dass S; Morrisey JM; Pou S; Nilsen A; Riscoe MK; Mather MW; Vaidya AB
    PLoS One; 2019; 14(4):e0214023. PubMed ID: 30964863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and functional analysis of the primary pantothenate transporter, PfPAT, of the human malaria parasite Plasmodium falciparum.
    Augagneur Y; Jaubert L; Schiavoni M; Pachikara N; Garg A; Usmani-Brown S; Wesolowski D; Zeller S; Ghosal A; Cornillot E; Said HM; Kumar P; Altman S; Ben Mamoun C
    J Biol Chem; 2013 Jul; 288(28):20558-67. PubMed ID: 23729665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.
    Price RN; Uhlemann AC; Brockman A; McGready R; Ashley E; Phaipun L; Patel R; Laing K; Looareesuwan S; White NJ; Nosten F; Krishna S
    Lancet; 2004 Jul 31-Aug 6; 364(9432):438-447. PubMed ID: 15288742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmodium falciparum carbonic anhydrase is a possible target for malaria chemotherapy.
    Reungprapavut S; Krungkrai SR; Krungkrai J
    J Enzyme Inhib Med Chem; 2004 Jun; 19(3):249-56. PubMed ID: 15499996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.